On July 9, 2020, ADBiotech Co., Ltd. (XKON:A179530) closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3,125 KRW | +1.13% |
|
-0.64% | -4.58% |
1st Jan change | Capi. | |
---|---|---|
-4.58% | 20.55M | |
-13.32% | 78.07B | |
+21.14% | 8.92B | |
+21.12% | 3.58B | |
+17.40% | 1.72B | |
-7.03% | 1.2B | |
-30.45% | 1.15B | |
-33.39% | 1.11B | |
-23.95% | 992M | |
+2.77% | 943M |
- Stock Market
- Equities
- A179530 Stock
- News ADBiotech Co., Ltd.
- ADBiotech Co., Ltd. announced that it has received KRW 3.0000065 billion in funding from SBI Investment Korea Co., Ltd.